Evidence map›Paper›PMID 27927067›Full record

ArticlePharmaceutical biology2017

Curcumin suppresses inflammatory cytokines and heat shock protein 70 release and improves metabolic parameters during experimental sepsis.

Letycia Silvano da Silva, Carlos Henrique Rocha Catalão, Tatiana Tocchini Felippotti, Gabriela Ravanelli de Oliveira-Pelegrin, Sérgio Petenusci, Luis Alexandre Pedro de Freitas, Maria José Alves Rocha

Registry-linked trialAbstract read
In one paragraph

Article in Pharmaceutical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07436130 (Immunomodulatory Effect of Curcumin in Critically Ill Patients With Sepsis at the Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde"), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07436130 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Immunomodulatory Effect of Curcumin in Critically Ill Patients With Sepsis at the Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde": A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

TypeinterventionalSponsorHospital Civil de GuadalajaraRan2026 to 2027Enrolled56ConditionsSepsisArmsCurcumin, Placebo
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Curcumin as a Potential Treatment for COVID-19.Frontiers in pharmacology · 2021
    Review
  9. Article
  10. Resveratrol Reduces Kidney Injury in a Rat Model of Uremia and is Associated with Increased Expression of Heat Shock Protein 70 (Hsp70).Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  11. HSP-Target of Therapeutic Agents in Sepsis Treatment.International journal of molecular sciences · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Letycia Silvano da Silvaa Department of Morphology, Physiology and Basic Pathology , School of Dentistry of Ribeirão Preto, University of São Paulo , Ribeirão Preto , São Paulo, Brazil.
Carlos Henrique Rocha Catalãob Department of Neuroscience and Behavior Sciences , Ribeirão Preto Medical School University of São Paulo , Ribeirão Preto , São Paulo, Brazil.
Tatiana Tocchini Felippottia Department of Morphology, Physiology and Basic Pathology , School of Dentistry of Ribeirão Preto, University of São Paulo , Ribeirão Preto , São Paulo, Brazil.
Gabriela Ravanelli de Oliveira-Pelegrina Department of Morphology, Physiology and Basic Pathology , School of Dentistry of Ribeirão Preto, University of São Paulo , Ribeirão Preto , São Paulo, Brazil.
Sérgio Petenuscia Department of Morphology, Physiology and Basic Pathology , School of Dentistry of Ribeirão Preto, University of São Paulo , Ribeirão Preto , São Paulo, Brazil.
Luis Alexandre Pedro de Freitasc Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto , University of São Paulo , Ribeirão Preto , São Paulo, Brazil.
Maria José Alves Rochaa Department of Morphology, Physiology and Basic Pathology , School of Dentistry of Ribeirão Preto, University of São Paulo , Ribeirão Preto , São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextCurcumin has been reported to have anti-inflammatory, antioxidant and hypoglycaemic properties, besides reducing mortality in sepsis.

objectiveThis study evaluates the biological activities of a curcumin dispersion formulated by spray-drying in experimental sepsis. MATERIALS AND

methodsMale Wistar rats were subjected to sepsis by caecal ligation and puncture (CLP), controls were sham operated. The animals were treated with curcumin dispersion (100 mg/kg, p.o.) or water for 7 days prior to CLP and at 2 h after surgery. One group was used to analyze curcumin absorption through HPLC; another had the survival rate assessed during 48 h; and from a third group, blood was collected by decapitation to analyze metabolic and inflammatory parameters.

resultsThe plasma curcumin levels reached 2.5 ng/mL at 4 h, dropped significantly (p < 0.001) at 6 h (1.2 ng/mL), and were undetectable at 24 h in both groups. Curcumin temporarily increased the survival rate of the septic rats by 20%. Moreover, it attenuated glycaemia (p < 0.05) and volemia (p < 0.05) alterations typically observed during sepsis, and decreased the levels of the proinflammatory cytokines IL-1β and IL-6 in plasma (p < 0.001) and peritoneal lavage fluid (p < 0.05) of septic rats. Serum HSP70 levels were decreased (p < 0.01) at 24 h after CLP. DISCUSSION AND

conclusionOur results show that the curcumin dispersion dose employed was not detrimental to the septic rats. In fact, it temporarily increased their survival rate, improved important metabolic parameters, reduced proinflammatory cytokines and HSP70 production.

Indexed as

AnimalsAnti-Inflammatory AgentsBiomarkersBlood GlucoseBlood VolumeCecumCurcuminCytokinesDisease Models, AnimalDosage FormsDown-RegulationDrug CompoundingHSP70 Heat-Shock ProteinsHypoglycemic AgentsInflammation MediatorsLigationAnti-Inflammatory AgentsBiomarkersBlood GlucoseCurcuminCytokinesDosage FormsHSP70 Heat-Shock ProteinsHypoglycemic AgentsInflammation MediatorsNitratesCLPglycaemiaHSP70nitric oxidevolemia

Identifiers

PMID27927067
PMCPMC6130593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.